Search Results Search Sort by RelevanceMost Recent Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156. Case and Commentary Mar 2022 Alignment of Abolition Medicine With Reproductive Justice Crystal M. Hayes, PhD, MSW and Anu Manchikanti Gomez, PhD Abolition medicine and reproductive justice are synergistic approaches that advance a radical vision of a racially just world. AMA J Ethics. 2022;24(3):E188-193. doi: 10.1001/amajethics.2022.188. History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.
Medicine and Society Feb 2021 How Can the Experiences of Black Women Living With HIV Inform Equitable and Respectful Reproductive Health Care Delivery? Faith E. Fletcher, PhD, MA, Ndidiamaka Amutah-Onukagha, PhD, MPH, Julie Attys, MPH, and Whitney S. Rice, DrPH, MPH Black women living with HIV contend with injuries of injustice that influence their reproductive lives. AMA J Ethics. 2021;23(2):E156-165. doi: 10.1001/amajethics.2021.156.
Case and Commentary Mar 2022 Alignment of Abolition Medicine With Reproductive Justice Crystal M. Hayes, PhD, MSW and Anu Manchikanti Gomez, PhD Abolition medicine and reproductive justice are synergistic approaches that advance a radical vision of a racially just world. AMA J Ethics. 2022;24(3):E188-193. doi: 10.1001/amajethics.2022.188.
History of Medicine Sep 2021 FDA Device Oversight From 1906 to the Present Anna Pisac and Natalia Wilson, MD, MPH A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices. AMA J Ethics. 2021;23(9):E712-720. doi: 10.1001/amajethics.2021.712.